These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
7. [Extracorporeal photopheresis--treatment option in scleromyxedema?]. Durani BK; Bock M; Näher H Hautarzt; 2001 Oct; 52(10 Pt 2):938-41. PubMed ID: 11715388 [TBL] [Abstract][Full Text] [Related]
8. A prospective clinical trial of pulse therapy with glucocorticoid and cyclophosphamide in moderate to severe paraquat-poisoned patients. Lin JL; Leu ML; Liu YC; Chen GH Am J Respir Crit Care Med; 1999 Feb; 159(2):357-60. PubMed ID: 9927343 [No Abstract] [Full Text] [Related]
9. Scleromyxedema revisited. Pomann JJ; Rudner EJ Int J Dermatol; 2003 Jan; 42(1):31-5. PubMed ID: 12581140 [TBL] [Abstract][Full Text] [Related]
10. Dexamethasone-cyclophosphamide pulse therapy in pemphigus: a review of 72 cases. Zivanovic D; Medenica L; Tanasilovic S; Vesic S; Skiljevic D; Tomovic M; Nikolic MM Am J Clin Dermatol; 2010; 11(2):123-9. PubMed ID: 20141233 [TBL] [Abstract][Full Text] [Related]
11. Cyclophosphamide-refractory scleroderma-associated interstitial lung disease: remarkable clinical and radiological response to a single course of rituximab combined with high-dose corticosteroids. Haroon M; McLaughlin P; Henry M; Harney S Ther Adv Respir Dis; 2011 Oct; 5(5):299-304. PubMed ID: 21593063 [TBL] [Abstract][Full Text] [Related]
12. Hypocomplementaemic urticarial vasculitis: successful treatment with cyclophosphamide-dexamethasone pulse therapy. Worm M; Muche M; Schulze P; Sterry W; Kolde G Br J Dermatol; 1998 Oct; 139(4):704-7. PubMed ID: 9892919 [TBL] [Abstract][Full Text] [Related]
13. Pretibial myxedema as the initial manifestation of Graves' disease. Georgala S; Katoulis AC; Georgala C; Katoulis EC; Hatziolou E; Stavrianeas NG J Eur Acad Dermatol Venereol; 2002 Jul; 16(4):380-3. PubMed ID: 12224697 [TBL] [Abstract][Full Text] [Related]
14. Dexamethasone cyclophosphamide pulse therapy in systemic lupus erythematosus: a case report. Gupta R; Gupta S; Khera V J Dermatolog Treat; 2009; 20(1):55-8. PubMed ID: 18618362 [TBL] [Abstract][Full Text] [Related]
16. Immediate and delayed complications of dexamethasone cyclophosphamide pulse (DCP) therapy. Jain R; Kumar B J Dermatol; 2003 Oct; 30(10):713-8. PubMed ID: 14684952 [TBL] [Abstract][Full Text] [Related]
17. Dexamethasone-cyclophosphamide pulse therapy in systemic lupus erythematosus. Dhabhai R; Kalla G; Singhi MK; Ghiya BC; Kachhawa D Indian J Dermatol Venereol Leprol; 2005; 71(1):9-13. PubMed ID: 16394353 [TBL] [Abstract][Full Text] [Related]
18. Repeated pulse of methylprednisolone and cyclophosphamide with continuous dexamethasone therapy for patients with severe paraquat poisoning. Lin JL; Lin-Tan DT; Chen KH; Huang WH Crit Care Med; 2006 Feb; 34(2):368-73. PubMed ID: 16424716 [TBL] [Abstract][Full Text] [Related]
19. [Scleromyxedema: a new therapeutic proposal]. Puiatti P; Goitre M G Ital Dermatol Venereol; 1986; 121(3):223-7. PubMed ID: 3017848 [No Abstract] [Full Text] [Related]
20. [Scleromyxedema therapy with isotretinoin]. Lominska-Lasota K; Rosen-Uzelac G; Reichl W; Bauer R Z Hautkr; 1988 Feb; 63(2):137-8, 141. PubMed ID: 3163867 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]